Swertisin
Swertisin Basic information
- Product Name:
- Swertisin
- Synonyms:
-
- SWERTISIN
- APIGENIN 6-GLUCOSYL-7-O-METHYL ETHER
- 4',5-Dihydroxy-7-methoxy-6-β-D-glucopyranosylflavone
- 6-(β-D-Glucopyranosyl)-5-hydroxy-2-(4-hydroxyphenyl)-7-methoxy-4H-1-benzopyran-4-one
- SWERTISIN(P)
- Genkwanin 6-C-Glucoside
- Swertisin, 98%, from Swertia diluta (Turcz.) Benth. & Hook.f.
- Swertia flavin
- CAS:
- 6991-10-2
- MF:
- C22H22O10
- MW:
- 446.4
- Product Categories:
-
- Tetra-substituted Flavones
- Mol File:
- 6991-10-2.mol
Swertisin Chemical Properties
- Melting point:
- 245-246℃
- Boiling point:
- 716.6±60.0 °C(Predicted)
- Density
- 1.583±0.06 g/cm3(Predicted)
- storage temp.
- Store at -20°C
- solubility
- Soluble in DMSO; sparingly soluble in methanol;
- pka
- 5.76±0.40(Predicted)
- form
- powder
- color
- White-pale yellow
- Water Solubility
- slightly soluble in water
Swertisin Usage And Synthesis
Chemical Properties
Swertisin is a flavonoid compound that appears as a light yellow powder or crystalline powder at room temperature. Its chemical formula is C22H22O10, with a molecular weight of 446. it is soluble in organic solvents such as methanol and dimethyl sulfoxide. It has antioxidant,anti-diabetic, anti-depressant, anti-inflammatory, anti-viral, and anti-radiation pharmacological effects.
Uses
food and beverages
Definition
ChEBI: Swertisin is a flavone C-glycoside that is 7-O-methylapigenin in which the hydrogen at position 6 has been replaced by a beta-D-glucosyl residue. It has a role as a plant metabolite, an adenosine A1 receptor antagonist, an anti-inflammatory agent, an antioxidant and a hypoglycemic agent. It is a flavone C-glycoside, a monosaccharide derivative, a polyphenol, a monomethoxyflavone and a dihydroxyflavone. It is functionally related to an apigenin.
Biological Activity
Swertisin is a flavonoid C-glycoside that has been found in Swertia japonica and has diverse biological activities. It inhibits sodium-glucose cotransporter 2 (SGLT2) in HEK293 cells when used at a concentration of 7.5 μg/ml and is an adenosine A1 receptor antagonist (IC50 = 137 μM). Swertisin (0.2-5 μM) inhibits hepatitis B virus (HBV) replication in HepG2 2.2.15 cells. It decreases blood glucose levels in a mouse model of diabetes induced by streptozotocin (Item No. 13104), as well as prevents scopolamine-induced increases in escape latency in the Morris water maze in mice.
in vivo
Swertisin (30 mg/kg, orally, single dose) helps improve symptoms of schizophrenia in mice, including sensory motor gating disruptions and cognitive impairments[1].
Swertisin (2.5 mg/kg, intraperitoneally, once daily, days) reduces the expression of SGLT2 in mouse kidney tissue and can quickly lower blood sugar[2].
Swertisin (0-10 mg/kg, intraperitoneally, every other day, 20 days) significantly inhibits HBV replication in a HBV transgenic mouse model[3].
| Animal Model: | Mice induced by MK801 (HY-15084B)[1] |
| Dosage: | 30 mg/kg; single dose |
| Administration: | Oral gavage (p.o.) |
| Result: | Alleviated the pre-pulse inhibition defect, reversed memory recognition impairment, and the elevated phosphorylation levels of Akt and GSK-3β signaling molecules in the prefrontal cortex restore normal function. |
| Animal Model: | BALB/c mice induced by STZ (HY-13753)[2] |
| Dosage: | 2.5 mg/kg; daily; 15 days |
| Administration: | Intraperitoneal injection (i.p.) |
| Result: | Improved overall glucose homeostasis, reduced SGLT2 expression in renal tissue, reduced PKC expression, and had a rapid hypoglycemic effect. |
| Animal Model: | HBV transgenic mice[3] |
| Dosage: | 0, 5, 10 mg/kg; every other day; 20 days |
| Administration: | Intraperitoneal injection (i.p.) |
| Result: | Showed that there was no significant weight loss, no significant changes in serum ALT and AST levels, and reduced serum HBsAg and HBeAg levels. |
IC 50
SGLT2
References
[1] GURPRIT BHARDWAJ . Swertisin, a novel SGLT2 inhibitor, with improved glucose homeostasis for effective diabetes therapy[J]. Archives of biochemistry and biophysics, 2021, 710: Article 108995. DOI:10.1016/j.abb.2021.108995.
[2] K. PATEL D. P. Biological importance and therapeutic benefit of swertisin: An overview of medicinal importance and pharmacological activities[J]. Current Bioactive Compounds, 2022. DOI:10.2174/1573407218666220801113334.
[3] HONG-YAN XU . Anti-hepatitis B virus activity of swertisin isolated from Iris tectorum Maxim[J]. Journal of ethnopharmacology, 2020, 257: Article 112787. DOI:10.1016/j.jep.2020.112787.
SwertisinSupplier
- Tel
- 025-83697070
- info@chemlin.com.cn
- Tel
- 0411-62910999 13889544652
- sales@meilune.com
- Tel
- +86-028-82633397 18982077548
- cwb1@biopurify.cn
- Tel
- 021-51320588
- tauto@tautobiotech.com
- Tel
- 021-021-33632979 15002134094
- marketing@targetmol.com
Swertisin(6991-10-2)Related Product Information
- Guaifenesin
- 4-Hexyloxyphenol
- 2,4,5-Trimethoxybenzaldehyde
- 5,6-DIHYDROXY-7-METHOXYFLAVONE
- Pashanone
- cirsimaritin
- 3-(METHOXYMETHOXY)BENZALDEHYDE
- 2-BENZYLOXY-4,5-DIMETHOXYBENZALDEHYDE
- APIGENIN 6-GLUCOSYL-7-O-METHYL ETHER
- HISPIDULIN
- 2' 5'-DIETHOXYACETOPHENONE 97
- 3-ETHOXYSALICYLALDEHYDE
- SCUTELLAREIN
- Arbutin
- MOSLOFLAVONE
- 6-HYDROXYFLAVONE-BETA-D-GLUCOSIDE
- 3-(4-METHOXYPHENOXY)-1-PROPANOL 98
- 1-(4-METHOXYPHENOXY)-2-PROPANOL